Phillip Mertz
Director/Board Member at ALPHA COGNITION INC.
Net worth: 728 377 $ as of 2024-03-30
Phillip Mertz active positions
Companies | Position | Start | End |
---|---|---|---|
ALPHA COGNITION INC. | Director/Board Member | 2021-03-21 | - |
Career history of Phillip Mertz
Former positions of Phillip Mertz
Companies | Position | Start | End |
---|---|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
Training of Phillip Mertz
Harvard University | Undergraduate Degree |
Statistics
International
United States | 2 |
Canada | 2 |
2 |
Operational
Director/Board Member | 3 |
Founder | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
Alpha Cognition, Inc. |
- Stock Market
- Insiders
- Phillip Mertz
- Experience